New York State Common Retirement Fund’s Unity Biotechnology UBX Stock Holding History

New York State Common Retirement Fund’s Portfolio UBX Stock Details UBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-28	Closed	-$1K	–	3523
2021 Q2	$1K	Sell	28 -2,532	-99%	-$122K	﹤0.01%	3474
2021 Q1	$154K	Hold	2,560	–	–	﹤0.01%	2928
2020 Q4	$134K	Hold	2,560	–	–	﹤0.01%	2901
2020 Q3	$89K	Hold	2,560	–	–	﹤0.01%	2977
2020 Q2	$222K	Hold	2,560	–	–	﹤0.01%	2589
2020 Q1	$148K	Hold	2,560	–	–	﹤0.01%	2608
2019 Q4	$185K	Buy	2,560 +80	+3%	+$5.64K	﹤0.01%	2772
2019 Q3	$151K	Hold	2,480	–	–	﹤0.01%	2900
2019 Q2	$236K	Hold	2,480	–	–	﹤0.01%	2736
2019 Q1	$201K	Buy	2,480 +1,800	+265%	+$204K	﹤0.01%	2721
2018 Q4	$111K	Hold	680	–	–	﹤0.01%	2935
2018 Q3	$111K	Hold	680	–	–	﹤0.01%	3030
2018 Q2	$102K	Buy	+680	New	+$99.4K	﹤0.01%	3082

Other funds holding UBX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FFVM

Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

New York State Common Retirement Fund's UBX Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of Unity Biotechnology (UBX) in Q3 2021, closing a stake of 28 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in UBX in Q2 2018 and held it in 13 quarters. The position peaked at $236K in Q2 2019. 84 funds tracked by Wall St. Rank hold UBX as of Q3 2021.

New York State Common Retirement Fund reported no remaining Unity Biotechnology position as of Q3 2021 after selling out during the quarter.
New York State Common Retirement Fund sold 28 Unity Biotechnology shares in Q3 2021, an estimated $1K.
New York State Common Retirement Fund first reported a position in Unity Biotechnology in Q2 2018 and held it in 13 quarters.
New York State Common Retirement Fund's Unity Biotechnology position peaked at $236K in Q2 2019.
84 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.